AMARIN CORP PLC\UK AMRN

Latest FY: 2025 Healthcare Drug Manufacturers - General
Market Price $14.04
Market Cap $296.71M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-6.5% YoY
$213.65M
3-Yr CAGR: -16.7%
Net Income ↑52.8% YoY
-$38.80M
Net Margin: -18.2%
Free Cash Flow ↑121.7% YoY
$6.70M
FCF Yield: 2.26%
EPS (Diluted) ↑55.0% YoY
$-0.09
Basic: $-0.09
Return on Equity Efficiency
-8.4%
ROA: -159.3%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (AMRN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $130.1M $95.7M $-86.3M $-0.41 $-71.8M $-71.8M
FY 2017 $181.1M +39.2% $136.2M $-67.9M +21.4% $-0.25 +39.0% $-32.8M $-32.8M +54.3%
FY 2018 $229.2M +26.6% $174.7M $-116.4M -71.6% $-0.39 -56.0% $-94.7M $-94.8M -188.5%
FY 2019 $429.8M +87.5% $333.7M $-22.6M +80.6% $-0.07 +82.1% $-9.4M $-11.8M +87.5%
FY 2020 $614.1M +42.9% $482.6M $-18.0M +20.5% $-0.05 +28.6% $-21.7M $-22.0M -85.7%
FY 2021 $583.2M -5.0% $461.9M $7.7M +142.9% $0.02 +140.0% $-66.5M $-66.5M -202.5%
FY 2022 $369.2M -36.7% $283.3M $-105.8M -1,468.9% $-0.26 -1,400.0% $-180.1M $-180.7M -171.5%
FY 2023 $306.9M -16.9% $165.5M $-59.1M +44.1% $-0.15 +42.3% $6.9M $6.9M +103.8%
FY 2024 $228.6M -25.5% $81.4M $-82.2M -39.0% $-0.20 -33.3% $-31.0M $-31.0M -552.5%
FY 2025 $213.6M -6.5% $120.9M $-38.8M +52.8% $-0.09 +55.0% $6.7M $6.7M +121.7%
$

Valuation

Market Price $14.04
Market Cap $296.71M
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 0.64
FCF Yield 2.26%
Dividend Yield N/A
Shares Outstanding 20,969,108
%

Profitability & Margins

Gross Margin 56.57%
Operating Margin -23.48%
Net Margin -18.16%
Return on Equity (ROE) -8.45%
Return on Assets (ROA) -159.33%
Asset Turnover 8.77x
Revenue 3-Yr CAGR -16.67%
🛡️

Financial Health & Liquidity

Current Ratio 0.13
Cash Ratio 0.69
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $134.66M
Total Debt N/A
Book Value / Share $21.90
💧

Cash Flow Efficiency

Operating Cash Flow $6.73M
Capital Expenditures (CapEx) $24.00K
Free Cash Flow $6.70M
OCF / Revenue 3.15%
FCF / Revenue 3.14%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-0.09
EPS (Basic) $-0.09
Dividends / Share N/A
Book Value / Share $21.90
EPS YoY Growth 55.00%
🏛️

Balance Sheet (FY 2025)

Total Assets $24.35M
Total Liabilities $194.46M
Stockholders' Equity $459.28M
Current Assets $24.35M
Current Liabilities $194.46M